Corporate Sponsored Funding

PIVOT Center works with companies to thoroughly understand their R&D goals and match them to research goals of the appropriate faculty members at the University of Utah. PIVOT’s Corporate Engagement team works across all schools and units to facilitate partnerships and offer expertise on identifying opportunities that include grant funding, sponsored research and creating strategic corporate partnerships. PIVOT also provides guidance to faculty for successful stewardship. Please contact Sadhna Kohli (Director of Corporate Engagement) for more information regarding these opportunities, or if you have any questions.

---

Pfizer: COVID-19 Vaccine Patient Education: Addressing Vaccine Hesitancy
Amount: $10-100K
Deadline: February 10, 2021

The intent is to support patient education programs designed to increase the understanding and familiarity with COVID-19 and COVID-19 vaccination among the general population. Of particular interest are educational programs that focus on reaching the medically underserved and other under-immunized populations including those in both rural and urban settings. All activity types will be considered, though given the current circumstances, virtual and digital activities will be prioritized. This includes applications to repurpose existing educational resources into easy-to-use and easy-to-access delivery formats (e.g. mobile apps.) We will also consider applications repurposing education or training resources that currently exist in one language but could be modified and translated to other languages and rolled out in different geographies.

Click here to learn more!

---

Pfizer: 2021 Ulcerative Colitis Competitive Grant Program
Amount: $75,000 to $150,000
Deadline: February 16^th, 2021

The intent of this Request for Proposal (RFP) is to support both clinical and basic science research on the pathogenesis and treatment of Ulcerative Colitis (UC) with a specific focus on projects that are most relevant to improving patient care.

Click here to learn more!

---

Pfizer: Understanding Residual Cardiovascular Risk Related to Triglyceride-Rich Remnant Lipoproteins
Amount: $100,000 to $150,000
Deadline: February 18^th, 2021

Through this RFP, the intention is to support educational programs focused on understanding residual cardiovascular (CV) risk associated with triglyceride (TG)-rich remnant lipoproteins

Click here to learn more!

---

Ono Pharma Breakthrough Science Initiative Awards Program
Amount: $900,000 for three years, and additional institutional indirect costs up to 15%.
Deadline: February 18, 2021, 5pm ET

Proposals from Principal Investigators will be considered for high-risk and high-reward science research projects which have potential to lead to science discoveries/solutions and, based on further research, to breakthrough treatments for patients. Applications will be considered from Principal Investigators in the Chemical Biology field for laboratory investigation to be carried out in the United States and Canada.

Click here to learn more!

---

Pfizer: Inflammatory and Immune-Mediated Dermatologic Disorders
Amount: $175,000
Deadline: February 24^th, 2021

Proposals from Principal Investigators will be considered for high-risk and high-reward science research projects which have potential to lead to science discoveries/solutions and, based on further research, to breakthrough treatments for patients. Applications will be considered from Principal Investigators in the Chemical Biology field for laboratory investigation to be carried out in the United States and Canada.

Click here to learn more!

---

Agilent Early Career Professor Award
Amount: $100,000
Deadline: February 26, 2021

2021 Focus: Contributions to the development of breakthrough solutions to understand or manage immunological responses to infection, autoimmunity or cancer.

Click here to learn more!

---

Paul Janssen Award for Biomedical Research
Amount: $200,000
Deadline: February 28, 2021

The Selection Committee will choose a scientist (or a group of scientists), in basic or clinical research, who:

• Has made a significant contribution to research that has impacted, or has strong potential to impact, human health through the diagnosis, treatment, or prevention of disease.
• Exhibits the standards of innovation, insight, and leadership that Dr. Paul exemplified during his career.
• Provides a living example that the study of science and technology can enable or has the potential to enable extended, healthy, productive life.

Click here to learn more!

---

Pfizer: 2021 Global Hemophilia ASPIRE
Amount: $70,000 to $90,000
Deadline: March 1^st, 2021

Projects that will be considered for Pfizer support will focus on the following areas:

1. Basic and Clinical Science of Gene Therapy for Hemophilia
2. Basic and Clinical Science of Tissue Factor Pathway Inhibitor (TFPI) and anti-TFPI monoclonal
3. Burden of disease: Clinical Hemophilia A and B

Note: Pfizer will not supply any study drug

Click here to learn more!

---

Comcast: Innovation Fund
Amount: $150,000
Deadline: Rolling submissions starting January 1^st, 2021 until funds are exhausted

Covid-19 effects on the Internet is a special focus area of interest for the 2021 funding year. Other areas of interest include proposals related to Network and User Security; All things Video, including Caching, Streaming, Transport, Encoding, Distribution and Production; Content Delivery Networks; DNS Operations and Management; Encrypted DNS; Broadband; Routing; Home Security; Network Optimization and Measurement; Faster Wifi, etc.

Click here to learn more!

---

Pediatric Networks for the Human Cell Atlas
Amount: Varies, budget limit has not been set on a per project basis
Deadline: March 30, 2021

The Chan Zuckerberg Initiative invites applications for three-year collaborative projects for the generation of healthy, single-cell reference data from pediatric tissue samples for the Human Cell Atlas (HCA).

Click here to learn more!

 

Blog Search